The MCP-3/Ccr3 axis contributes to increased bone mass by affecting osteoblast and osteoclast differentiation

  • Kim, Jung Ha; 
  • Kim, Kabsun; 
  • Kim, Inyoung; 
  • Seong, Semun; 
  • Che, Xiangguo; 
  • ... Choi, Je-Yong; 
  • 외 2명
Citations

WEB OF SCIENCE

6
Citations

SCOPUS

6

초록

Several CC subfamily chemokines have been reported to regulate bone metabolism by affecting osteoblast or osteoclast differentiation. However, the role of monocyte chemotactic protein 3 (MCP-3), a CC chemokine, in bone remodeling is not well understood. Here, we show that MCP-3 regulates bone remodeling by promoting osteoblast differentiation and inhibiting osteoclast differentiation. In a Ccr3-dependent manner, MCP-3 promoted osteoblast differentiation by stimulating p38 phosphorylation and suppressed osteoclast differentiation by upregulating interferon beta. MCP-3 increased bone morphogenetic protein 2-induced ectopic bone formation, and mice with MCP-3-overexpressing osteoblast precursor cells presented increased bone mass. Moreover, MCP-3 exhibited therapeutic effects by abrogating receptor activator of nuclear factor kappa-B ligand-induced bone loss. Therefore, MCP-3 has therapeutic potential for diseases involving bone loss due to its positive role in osteoblast differentiation and negative role in osteoclast differentiation. Our bones are always changing, needing a balance between bone creation and bone breakdown. Researchers investigates how a specific protein, MCP-3, affects this balance. They found that MCP-3 promotes the creation of osteoblasts and stops the creation of osteoclasts. The study involved both in vitro and in vivo methods, looking at how changing MCP-3 levels impacts bone change processes. Researchers found that increasing MCP-3 levels in bone-making cells resulted in stronger bones in mice, suggesting MCP-3 is key in promoting bone creation and stopping excessive bone loss. This was partly due to MCP-3's interaction with specific cell receptors and signaling pathways that affect bone cell activity. This research paves the way for future studies on MCP-3 as a target for bone-strengthening therapies, potentially leading to new treatments for diseases that weaken bones. This summary was initially drafted using artificial intelligence, then revised and fact-checked by the author.

키워드

INDUCTION; MICE
제목
The MCP-3/Ccr3 axis contributes to increased bone mass by affecting osteoblast and osteoclast differentiation
저자
Kim, Jung Ha; Kim, Kabsun; Kim, Inyoung; Seong, Semun; Che, Xiangguo; Choi, Je-Yong; Koh, Jeong-Tae; Kim, Nacksung
DOI
10.1038/s12276-024-01344-6
발행일
2024-11
유형
Article
저널명
Experimental & Molecular Medicine
권
56
호
11
페이지
2465 ~ 2474